You are here

COVID-19

CDC panel signals support for COVID-19 booster shots for immunocompromised people

Beckers Hospital Review

Mon, 07/26/21 - 09:33 am

Abbott Turns Focus Back to Core Growth Drivers

Medical Devices and Diagnostics Industry

Mon, 07/26/21 - 09:31 am

Study finds vaccines cut severe variant COVID disease after one shot

Pharmaforum

Fri, 07/23/21 - 11:13 am

real world evidence

Delta COVID-19 variant

Abbott latest to report pandemic recovery in Q2 as procedures return, COVID-19 tests drag diagnostics

Medtech Dive

Fri, 07/23/21 - 11:08 am

The Delta Variant Will Drive A Steep Rise In U.S. COVID Deaths, A New Model Shows

NPR

Thu, 07/22/21 - 10:07 pm

Delta COVID-19 variant

J&J’s COVID-19 shot scores safety backing from CDC experts but booster need left for FDA

Fierce Pharma

Thu, 07/22/21 - 09:58 pm

Two doses of Pfizer, AstraZeneca shots effective against Delta variant: study

Reuters

Wed, 07/21/21 - 09:09 pm

Delta COVID-19 variant

J&J shot may be significantly less effective against delta variant, small study hints

Beckers Hospital Review

Wed, 07/21/21 - 08:57 pm

Delta COVID-19 variant

COVID-19 variants

The FDA may not fully approve a COVID-19 vaccine until January. Here’s why

Marketwatch

Wed, 07/21/21 - 11:05 am

EMA starts review of latecomer GSK/Sanofi COVID-19 vaccine

Pharmaforum

Tue, 07/20/21 - 11:58 pm

Delta variant surges to 83% of sequenced Covid-19 cases in the U.S., CDC says

Stat

Tue, 07/20/21 - 12:46 pm

Delta COVID-19 variant

3 Areas Where Pfizer Is Crushing Moderna

Motley Fool

Tue, 07/20/21 - 11:08 am

Moderna Therapeutics

Medical meetings post-COVID – key lessons for pharma

Pharmaforum

Tue, 07/20/21 - 11:05 am

virtual meetings

States are sitting on millions of surplus Covid-19 vaccine doses as expiration dates approach

Stat

Tue, 07/20/21 - 11:04 am

What happened to Novavax's COVID-19 vaccine candidate?

Beckers Hospital Review

Mon, 07/19/21 - 11:21 pm

FDA grants priority review for Pfizer COVID-19 vaccine BLA

Biopharma Reporter

Mon, 07/19/21 - 10:59 am

priority review

COVID-19 drug developer Adagio plans IPO to cap fast rise

BioPharma Dive

Mon, 07/19/21 - 10:57 am

Adagio Therapeutics

Moderna's Joining the S&P 500: What's Next for the Hot Vaccine Stock?

Motley Fool

Mon, 07/19/21 - 10:52 am

Moderna Therapeutics

Meissa Vaccines’ leg up in the Covid-19 vaccines chase goes through the nose

MedCity News

Mon, 07/19/21 - 10:50 am

Meissa Vaccines

intranasal vaccines

How Delta is pushing the U.S. into a new phase of the Covid-19 pandemic

Stat

Mon, 07/19/21 - 10:48 am

Delta COVID-19 variant

Pages